Impact of SVV Guided Intraoperative Artificial Colloid Infusion on Postoperative Coagulation and Occult Blood Loss: A Randomized Controlled Study

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-15006432

Enrollment

Unknown

Registered

2015-05-13

Start date

2015-05-21

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative coagulation and occult blood loss

Interventions

Voluven Group:SVV guided intraoperative Voluven transfusion

Gelofusine Group:SVV guided intraoperative Gelofusine transfusion

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Expected blood loss<700ml; 2. No intraoperative infusion of blood products; 3. Aged between 18-45 years; 4. Weighted 55-80kg; 5. No medical history of arrhythmias; 6. Agreed to participate in the study and signed a written informed consent.

Exclusion criteria

Exclusion criteria: 1. Expected blood loss>700ml; 2. Intraoperative infusion of blood products; 3. Aged between 45 years; 4. Weighted 80kg; 5. Past medical history of arrhythmias; 6. Disagreed to participate in the study.

Design outcomes

Primary

Measure	Time frame
Maximum Amplitude;	—

Secondary

Measure	Time frame
Activated Clotting Time;R Time;K Time;alpha Angle;Hematocrit;Height;Weight;	—

Countries

China

Contacts

Public ContactShangyi Hui

huishangyi@126.com+86 13521366665

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026